# Yongchang Zhang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yongchang-zhang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,225 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 28 |
| i10-index | 86 |
| Last Known Institution | Qinghai University |
| OpenAlex ID | https://openalex.org/A5101498093 |
| ORCID iD | 0000-0002-6829-7176 |
| Works | 245 |

## Researcher papers

- [ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis](https://scholariq.org/papers/adora1-inhibition-promotes-tumor-immune-evasion-by-regulating-the-atf3-pd-l1/)
- [Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1](https://scholariq.org/papers/small-molecule-mmp2-mmp9-inhibitor-sb-3ct-modulates-tumor-immune-surveillance-by/)
- [Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy](https://scholariq.org/papers/association-between-sex-and-immune-related-adverse-events-during-immune/)
- [Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy](https://scholariq.org/papers/effective-treatment-of-lung-adenocarcinoma-harboring-egfr-activating-mutation/)
- [Spatial immune scoring system predicts hepatocellular carcinoma recurrence](https://scholariq.org/papers/spatial-immune-scoring-system-predicts-hepatocellular-carcinoma-recurrence/)
- [The efficacy of music therapy to relieve pain, anxiety, and promote sleep quality, in patients with small cell lung cancer receiving platinum-based chemotherapy](https://scholariq.org/papers/the-efficacy-of-music-therapy-to-relieve-pain-anxiety-and-promote-sleep-quality/)
- [Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study](https://scholariq.org/papers/genomic-alterations-and-clinical-outcomes-in-patients-with-lung-adenocarcinoma/)
- [Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China](https://scholariq.org/papers/anlotinib-combined-with-pd-1-blockade-for-the-treatment-of-lung-cancer-a-real/)
- [Targeting ALK Rearrangements in NSCLC: Current State of the Art](https://scholariq.org/papers/targeting-alk-rearrangements-in-nsclc-current-state-of-the-art/)
- [Detection of Nonreciprocal/Reciprocal ALK Translocation as Poor Predictive Marker in Patients With First-Line Crizotinib-Treated ALK-Rearranged NSCLC](https://scholariq.org/papers/detection-of-nonreciprocal-reciprocal-alk-translocation-as-poor-predictive/)
- [Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer](https://scholariq.org/papers/clinical-impact-of-uncommon-epidermal-growth-factor-receptor-exon-19-insertion/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Qinghai University](https://scholariq.org/institutions/qinghai-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.